An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Nagelhout G, Ebisch RM, Van Der Hel O, Meerkerk GJ, Magnée T, De Bruijn T, Van Straaten B.Nagelhout G, et al. Among authors: van der hel o.Expert Rev Anticancer Ther. 2021 Jul;21(7):781-794. doi: 10.1080/14737140.2021.1888719. Epub 2021 Mar 5.Expert Rev Anticancer Ther. 2021.PMID: 33663309
van der Hel OL, Bueno de Mesquita HB, Sandkuijl L, van Noord PA, Pearson PL, Grobbee DE, Peeters PH.van der Hel OL, et al.Cancer Causes Control. 2003 Apr;14(3):293-8. doi: 10.1023/a:1023601922106.Cancer Causes Control. 2003.PMID: 12814209
Heesterman BL, Aben KKH, de Jong IJ, Pos FJ, van der Hel OL.Heesterman BL, et al. Among authors: van der hel ol.BMC Cancer. 2023 May 4;23(1):398. doi: 10.1186/s12885-023-10842-1.BMC Cancer. 2023.PMID: 37142955Free PMC article.
van der Hel OL, Peeters PH, Hein DW, Doll MA, Grobbee DE, Kromhout D, Bueno de Mesquita HB.van der Hel OL, et al.Pharmacogenetics. 2003 Jul;13(7):399-407. doi: 10.1097/00008571-200307000-00005.Pharmacogenetics. 2003.PMID: 12835615
van der Hel OL, Bueno de Mesquita HB, Roest M, Slothouber B, van Gils C, van Noord PA, Grobbee DE, Peeters PH.van der Hel OL, et al.Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):681-2.Cancer Epidemiol Biomarkers Prev. 2003.PMID: 12869413No abstract available.
Timmermans M, van der Hel O, Sonke GS, Van de Vijver KK, van der Aa MA, Kruitwagen RF.Timmermans M, et al. Among authors: van der hel o.Gynecol Oncol. 2019 May;153(2):445-451. doi: 10.1016/j.ygyno.2019.02.019. Epub 2019 Feb 27.Gynecol Oncol. 2019.PMID: 30826010
van der Horst RL, van der Hel O, Lutgens L, van der Aa M, Slangen B, Kruitwagen R, Lalisang RI.van der Horst RL, et al. Among authors: van der hel o.Crit Rev Oncol Hematol. 2022 Jul;175:103701. doi: 10.1016/j.critrevonc.2022.103701. Epub 2022 May 6.Crit Rev Oncol Hematol. 2022.PMID: 35533817Free article.Review.
van der Hel OL, Bueno-de-Mesquita HB, van Gils CH, Roest M, Slothouber B, Grobbee DE, Peeters PH.van der Hel OL, et al.Cancer Causes Control. 2005 Aug;16(6):675-81. doi: 10.1007/s10552-005-1227-0.Cancer Causes Control. 2005.PMID: 16049806Clinical Trial.
van der Hel OL, Timmermans M, van Altena AM, Kruitwagen RFPM, Slangen BFM, Sonke GS, van de Vijver KK, van der Aa MA.van der Hel OL, et al.Eur J Cancer. 2019 Sep;118:97-104. doi: 10.1016/j.ejca.2019.06.005. Epub 2019 Jul 18.Eur J Cancer. 2019.PMID: 31326731
Walraven JEW, van der Hel OL, van der Hoeven JJM, Lemmens VEPP, Verhoeven RHA, Desar IME.Walraven JEW, et al. Among authors: van der hel ol.BMC Health Serv Res. 2022 Jun 27;22(1):829. doi: 10.1186/s12913-022-08112-0.BMC Health Serv Res. 2022.PMID: 35761282Free PMC article.